GridAI Technologies Corp. (GRDX)
NASDAQ: GRDX · Real-Time Price · USD
6.47
-0.33 (-4.85%)
Jun 2, 2026, 4:00 PM EDT - Market closed
Company Description
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources.
It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.
The company is based in Edinburgh, United Kingdom.
GridAI Technologies Corp.
| Country | United Kingdom |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Jason David Sawyer |
Contact Details
Address: 91 George St Edinburgh, EH2 3ESL United Kingdom | |
| Website | grid-ai.com |
Stock Details
| Ticker Symbol | GRDX |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| CIK Code | 0001604191 |
| CUSIP Number | 33749P507 |
| ISIN Number | US33749P5070 |
Key Executives
| Name | Position |
|---|---|
| Marshall Chapin | Chief Executive Officer of GridAI, Inc |
| Jason David Sawyer | Chief Executive Officer and Director |
| Anna Skowron | Interim Chief Financial Officer |